# COXANTO

NDC: 70512-814
Generic name: oxaprozin
Labeler / Manufacturer: SOLA Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20251103

FDA application: NDA217927

## Active ingredients

- OXAPROZIN: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70512-814"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70512-814
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=918127f0-9f2a-4edf-a2f7-07c01aa52bb5